Deep Brain Stimulation Systems Market Report 2026
Global Outlook – By Product (Single Channel, Dual Channel), By Application (Parkinson's Disease, Essential Tremor, Obsessive Compulsive Disorder, Epilepsy, Dystonia, Other Applications), By End-user (Hospitals, Ambulatory Surgical Centers, Neurological Clinics, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2030
Deep Brain Stimulation Systems Market Overview
• Deep Brain Stimulation Systems market size has reached to $2.77 billion in 2025 • Expected to grow to $4.52 billion in 2030 at a compound annual growth rate (CAGR) of 10.3% • Growth Driver: Rising Prevalence Of Neurological Disorders Ignites Growth In The Deep Brain Stimulation Systems Market • Market Trend: Launch Of World's Smallest Rechargeable Deep Brain Stimulation Device With Remote Programming • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Deep Brain Stimulation Systems Market?
A deep brain stimulation (DBS) system is a medical device that uses implanted electrodes to deliver electrical pulses to specific areas of the brain. It is used to regulate abnormal brain activity and improve symptoms associated with a variety of neurological conditions. The main products of deep brain stimulation systems are single channel and dual channel systems. Single-channel brain stimulation systems are devices used to apply targeted electrical or magnetic stimulation to specific regions of the brain. They are used for various applications, including Parkinson's disease, essential tremor, obsessive compulsive disorder, epilepsy, dystonia, and others by several end-users, such as hospitals, ambulatory surgical centers, neurological clinics, and other end users.
What Is The Deep Brain Stimulation Systems Market Size and Share 2026?
The deep brain stimulation systems market size has grown rapidly in recent years. It will grow from $2.77 billion in 2025 to $3.05 billion in 2026 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to growing prevalence of neurological disorders, increasing clinical acceptance of neuromodulation therapies, advancements in implantable medical device technology, expansion of neurology specialty centers, improved long-term patient outcomes.What Is The Deep Brain Stimulation Systems Market Growth Forecast?
The deep brain stimulation systems market size is expected to see rapid growth in the next few years. It will grow to $4.52 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to increasing investments in next-generation neurostimulation devices, rising demand for personalized neurological treatments, expansion of dbs indications beyond movement disorders, growing integration of ai-driven programming, increasing focus on remote patient monitoring. Major trends in the forecast period include increasing adoption of adaptive dbs systems, rising use of image-guided electrode placement, growing demand for rechargeable neurostimulators, expansion of personalized neuromodulation therapies, enhanced focus on minimally invasive implantation techniques.
Global Deep Brain Stimulation Systems Market Segmentation
1) By Product: Single Channel, Dual Channel 2) By Application: Parkinson's Disease, Essential Tremor, Obsessive Compulsive Disorder, Epilepsy, Dystonia, Other Applications 3) By End-user: Hospitals, Ambulatory Surgical Centers, Neurological Clinics, Other End Users Subsegments: 1) By Single Channel: Unilateral Deep Brain Stimulation (DBS) Systems, Single Lead Deep Brain Stimulation (DBS) Systems, Targeted Single Nucleus DBS Systems, Standard Single Channel Neurostimulation Systems 2) By Dual Channel: Bilateral Deep Brain Stimulation (DBS) Systems, Dual Lead Deep Brain Stimulation (DBS) Systems, Multi-Nucleus Targeted DBS Systems, Advanced Dual Channel Neurostimulation SystemsWhat Is The Driver Of The Deep Brain Stimulation Systems Market?
The increasing prevalence of neurological disorders is expected to propel the growth of the deep brain stimulation systems market going forward. Neurological disorders refer to a group of heterogeneous diseases that affect the body's autonomic, peripheral, and central nervous systems. Deep brain stimulation systems are used in neurosurgical procedures to send electrical stimulation to the desired area, aiming to alter or modulate neural functioning and achieve a reversible, adjustable, and therapeutic effect. For instance, in October 2023, according to the World Federation of Neurology, a UK-based association of national neurological societies, more than 40% of the world’s population is affected by some form of neurological condition today, and this burden is expected to almost double by 2050. Therefore, the increasing prevalence of neurological disorders is driving the growth of the deep brain stimulation systems industry.Key Players In The Global Deep Brain Stimulation Systems Market
Major companies operating in the deep brain stimulation systems market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Aleva Neurotherapeutics SA, Beijing PINS Medical Co Ltd, SceneRay Corporation Ltd, NeuroPace Inc, LivaNova PLC, NeuroSigma Inc, Functional Neuromodulation Ltd, Synapse Biomedical Inc, Soterix Medical Inc, FHC Inc, Newronika S.p.A, Renishaw plc, Deep Brain Innovations LLC, BlueWind Medical Ltd, Magstim Company Ltd, Sapiens Steering Brain Stimulation, Bioinduction Ltd, Alpha Omega Engineering
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.
This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Explore how leading companies compare across key metrics in our report Get Report
Global Deep Brain Stimulation Systems Market Trends and Insights
Major companies operating in the deep brain stimulation systems market are developing innovative technology, such as deep brain stimulation (DBS) systems, to treat patients with movement disorders. Deep Brain Stimulation (DBS) is a medical procedure that involves an implanted device that delivers an electrical current directly to areas of the brain. For instance, in January 2024, Abbott Laboratories, a US-based medical devices and health care company, launched the Liberta RC DBS system, the world's smallest rechargeable deep brain stimulation (DBS) device with remote programming, to treat people living with movement disorders. The Liberta RC DBS system is the only rechargeable, first-of-its-kind connected care technology in the U.S. and enables patients to stay in touch with their physicians, guarantee optimal configuration and operation, and obtain updated treatment settings remotely when necessary without having to visit a physician's office.What Are Latest Mergers And Acquisitions In The Deep Brain Stimulation Systems Market?
In October 2025, Medtronic plc, a US-based medical device company that provides a full line of deep brain stimulation (DBS) technology and technical support, partnered with Siemens Healthineers for an undisclosed amount. This partnership aims to integrate advanced imaging into Medtronic’s AiBLE ecosystem, which encompasses surgical navigation and robotics, thereby enhancing the precision of electrode placement in neurosurgical procedures, including DBS for the treatment of movement disorders such as Parkinson’s disease. Siemens Healthineers, a Germany-based medical technology company.
Regional Outlook
North America was the largest region in the deep brain stimulation systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainNeed data for a specific geography? Request Regional Data
What Defines the Deep Brain Stimulation Systems Market?
The deep brain stimulation system market includes revenues earned by entities by providing services such as electrode implantation, pulse generator implantation, surgical implantation services, diagnostic and preoperative services, programming and adjustment services, patient education and support. The market value includes the value of related goods sold by the service provider or included within the service offering. The deep brain stimulation system market also includes of sales of extension wires, remote controls, and electrodes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.
This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
Access full TAM calculations and growth projections in our report Get Report
What Key Data and Analysis Are Included in the Deep Brain Stimulation Systems Market Report 2026?
The deep brain stimulation systems market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the deep brain stimulation systems industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Deep Brain Stimulation Systems Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $3.05 billion |
| Revenue Forecast In 2030 | $4.52 billion |
| Growth Rate | CAGR of 10.3% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Product, Application, End-user |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Aleva Neurotherapeutics SA, Beijing PINS Medical Co Ltd, SceneRay Corporation Ltd, NeuroPace Inc, LivaNova PLC, NeuroSigma Inc, Functional Neuromodulation Ltd, Synapse Biomedical Inc, Soterix Medical Inc, FHC Inc, Newronika S.p.A, Renishaw plc, Deep Brain Innovations LLC, BlueWind Medical Ltd, Magstim Company Ltd, Sapiens Steering Brain Stimulation, Bioinduction Ltd, Alpha Omega Engineering |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |